FHC
XBIT icon

Forest Hill Capital’s XBiotech XBIT Stock Holding History

Forest Hill Capital’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-45,000
Closed -$672K – 64
2015
Q3 		$672K Hold
45,000
– – 0.06% 61
2015
Q2 		$814K Buy
+45,000
New +$933K 0.07% 61

Other funds holding XBIT

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NFA
Nationwide Fund Advisors Columbus, Ohio $2.28B AUM 12.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Forest Hill Capital's XBIT Position: Q4 2015 in Review

Forest Hill Capital sold out of XBiotech (XBIT) in Q4 2015, closing a stake of 45,000 shares — an estimated $672K sold.

Forest Hill Capital first reported a position in XBIT in Q2 2015 and held it in 2 quarters. The position peaked at $814K in Q2 2015. 38 funds tracked by Wall St. Rank hold XBIT as of Q4 2015.

  • Forest Hill Capital reported no remaining XBiotech position as of Q4 2015 after selling out during the quarter.
  • Forest Hill Capital sold 45,000 XBiotech shares in Q4 2015, an estimated $672K.
  • Forest Hill Capital first reported a position in XBiotech in Q2 2015 and held it in 2 quarters.
  • Forest Hill Capital's XBiotech position peaked at $814K in Q2 2015.
  • 38 funds tracked by Wall St. Rank held XBiotech as of Q4 2015.

Based on Forest Hill Capital's 13F filing for Q4 2015, filed 16 Feb 2016.